导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 45.60% | 82/1050 |
| 近一周 | 2.80% | 161/1104 |
| 近一月 | -5.74% | 1009/1102 |
| 近一季 | -8.30% | 632/1092 |
| 近半年 | 43.44% | 31/1070 |
| 近一年 | 54.65% | 78/1018 |
| 近两年 | 178.26% | 80/926 |
| 近三年 | 114.26% | 84/834 |
| 成立以来 | 408.60% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-4.77% 798/1070 |
108.07% 21/1101 |
- - |
- - |
| 2025 | 51.23% 180/1065 |
8.82% 190/1014 |
-2.69% 874/1038 |
45.34% 122/1050 |
-1.74% 544/1065 |
| 2024 | 0.70% 561/1011 |
-2.79% 464/960 |
-6.55% 720/983 |
7.00% 818/991 |
3.59% 173/1011 |
| 2023 | -3.62% 175/952 |
19.93% 30/880 |
0.01% 193/895 |
-17.38% 824/915 |
-2.73% 297/952 |
| 2022 | -29.23% 605/867 |
-21.44% 599/773 |
16.26% 84/806 |
-21.50% 772/845 |
-1.30% 500/867 |
| 2021 | 43.92% 25/740 |
-12.40% 532/580 |
42.85% 4/659 |
9.75% 67/704 |
4.80% 239/740 |
| 2020 | 95.41% 45/554 |
-2.24% 221/419 |
33.82% 81/466 |
9.61% 258/517 |
36.27% 18/554 |
| 2019 | 62.40% 69/410 |
36.92% 108/1146 |
-8.49% 932/1228 |
6.90% 166/390 |
21.26% 11/410 |
| 2018 | 4.02% 1/349 |
- - |
-1.73% 112/990 |
-3.66% 401/1000 |
8.41% 1/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 金鹰信息产业股票A VS. 东吴新产业精选股票A(580008) |